The contribution of SLC7A11-mediated ferroptosis to cardiac injury in iron overload cardiomyopathy: an in vitro study

31 August 2024 (11:00 - 11:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Juxiang Hou

Kunming (China)

4 More presentations in this session

Presentation thumbnail

S-nitrosylation of aconitase-2 facilitates coronary microembolization-induced cardiac injury by suppressing iron-sulfur cluster assembly

Doctor Z. Chen (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Ferroptosis contributes to the development of cardiac dysfunction in iron overload cardiomyopathy

Miss X. Fan (Kunming, CN)

Abstract Slides Video

Presentation thumbnail

Vitamin K2 and the Vitamin-K-Cycle-Enzyme VKORC1L1 improve endothelial regeneration by inhibiting endothelial-mesenchymal transition, inflammatory cell activation and ferroptosis

Doctor M. Al Zaidi (Bonn, DE)

Abstract Slides Video

Presentation thumbnail

The contribution of iron metabolism to heart failure: a haematological and biochemical perspective

Doctor A. Melicio (Lisbon, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Ferroptosis and iron metabolism

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET

You may be interested in

Congress Presentation

Ferroptosis contributes to the development of cardiac dysfunction in iron overload cardiomyopathy

Congress Presentation

Iron chelation therapy failed to improve cardiac dysfunction caused by mitochondrial injury in rats with iron overload cardiomyopathy a 7T Cardiac MR research in vivo

Congress Presentation

Deciphering diagnostic markers and immune infiltration in ischemic cardiomyopathy: insights from cuproptosis-related genes via bioinformatics and experimental approaches

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources